Passive

Invesco S&P SmallCap Health Care ETF

The Invesco S&P SmallCap Health Care ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600® Capped Health Care Index (the “Underlying Index”).

$53.60

Key Metrics

TER 0.29% per year
Distribution policy Distributing
Fund size USD 140 M
Inception date April 7, 2010
Holdings 80
Fund currency USD
Fund domicile US
Provider Invesco
For full official fund details, factsheets, and holdings, visit invesco.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
S&P SmallCap Health Care ETF PSCH
Fund Size
$181M
Dividend
0.0%
Fees
0.29%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
0.04%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.0%
Fees
0.03%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
1.0%
Fees
-
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.0%
Fees
0.04%
View 1339 similar ETFs →

Historical Return

Last updated: Jul 01, 2026
1 Year +30.7% +0.0% Div
3 Years (avg.) +5.8% +0.0% Div
5 Years (avg.) -4.3% +0.0% Div

Risk & Analysis Metrics

Last updated: Jul 01, 2026

Volatility

19.68% 1 Year
21.22% 3 Years
22.50% 5 Years
23.37% 10 Years

Max Drawdown

-15.40% 1 Year
-23.01% 3 Years
-46.61% 5 Years
-47.32% 10 Years

Sharpe Ratio

1.10 1 Year
0.15 3 Years
-0.27 5 Years
0.26 10 Years

Return Triangle (Heatmap)

Last updated: Jul 01, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -63.1% -35.8% -14.3% -8.9% -3.5% -2.1% 2.3% 3.1% 4.9% 7.3% 7.1% 3.8% 3.3% 3.3% 3.0%
2012 12.0% 30.7% 23.1% 22.7% 19.0% 21.3% 19.4% 19.5% 20.8% 19.2% 14.0% 12.6% 11.8% 10.9%
2013 52.6% 29.1% 26.6% 20.8% 23.3% 20.6% 20.6% 22.0% 20.0% 14.2% 12.6% 11.8% 10.8%
2014 9.2% 15.2% 11.7% 16.9% 15.1% 16.0% 18.2% 16.5% 10.6% 9.2% 8.7% 7.9%
2015 21.6% 13.0% 19.5% 16.6% 17.4% 19.7% 17.6% 10.8% 9.2% 8.7% 7.7%
2016 5.0% 18.5% 15.0% 16.4% 19.3% 16.9% 9.3% 7.8% 7.3% 6.4%
2017 33.8% 20.4% 20.4% 23.2% 19.4% 10.1% 8.2% 7.6% 6.6%
2018 8.3% 14.2% 19.9% 16.1% 5.9% 4.4% 4.3% 3.6%
2019 20.5% 26.2% 18.8% 5.2% 3.7% 3.7% 3.0%
2020 32.1% 18.0% 0.6% -0.1% 0.6% 0.3%
2021 5.5% -12.2% -9.0% -6.0% -5.1%
2022 -26.9% -15.5% -9.6% -7.5%
2023 -2.4% 0.5% 0.0%
2024 3.5% 1.2%
2025 -1.1%

Distributions

*by ETF Portfolio Weight Last updated: Jul 01, 2026

Profit Margin Distribution

< 0%
37%
1y 3y N/A N/A
0 - 5%
14%
1y 3y N/A N/A
5 - 10%
14%
1y 3y N/A N/A
10 - 15%
7%
1y 3y N/A N/A
15 - 20%
6%
1y 3y N/A N/A
20 - 30%
5%
1y 3y N/A N/A
30 - 40%
4%
1y 3y N/A N/A
> 40%
13%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
36%
1y 3y N/A N/A
0 - 10
1%
1y 3y N/A N/A
10 - 15
13%
1y 3y N/A N/A
15 - 20
8%
1y 3y N/A N/A
20 - 25
6%
1y 3y N/A N/A
25 - 35
9%
1y 3y N/A N/A
35 - 50
15%
1y 3y N/A N/A
> 50
14%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.4%
1y 3y N/A N/A
Small Cap
22.5%
1y 3y N/A N/A
Mid Cap
69.4%
1y 3y N/A N/A
Large Cap
7.7%
1y 3y N/A N/A
Mega Cap
0.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jul 01, 2026
19.8% Top 5 Holdings
35.0% Top 10 Holdings
90.8% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
KRYS Krystal Biotech Inc
4.7%
GKOS Glaukos Corporation
4.5%
PTCT PTC Therapeutics Inc
3.6%
PTGX Protagonist Therapeutics Inc
3.5%
TFX Teleflex Incorporated
3.5%

Latest News

7 days ago • fool.com

Which Is the Better Long-Term Buy: iShares' Small-Cap IWM or Invesco's Tech-Heavy QQQ?

iShares Russell 2000 ETF targets small-cap growth and value stocks, while Invesco QQQ Trust, Series 1 focuses on the largest non-financial leaders ...
7 days ago • 247wallst.com

The Anti-Magnificent Seven Trade? VGK Is Quietly Creeping Toward Record Highs

European stocks are having their loudest year in a decade, and the Vanguard FTSE Europe ETF (NYSEARCA:VGK) is the vehicle most retail investors wil...
7 days ago • fool.com

The Stock Market Will Make History on July 7. Here's What Investors Need to Know Now.

SpaceX will be the first mega-IPO stock to join the Nasdaq-100 under its new fast-track entry rules.

Average metrics of all companies in portfolio

Last updated: Jul 12, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $4.66B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.14% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.99 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 44.12 29.97
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -32.15 -
Profitable Companies 66% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 22.53 16.04
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.76 8.54
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.97 10.59
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 6.92 20.58
Enterprise Value to Revenue Enterprise value divided by revenue 6.52 8.35
Total Debt to Enterprise Value Total debt divided by enterprise value 0.14 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.54 0.26
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 1.72% 21.03%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -26.6% -118.0%
Return on Equity Equity divided by market cap. 4.66% 2.68%
Return on Assets Indicates a company's profitability in relation to its total assets. 0.47% 4.06%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 1.64% 3.64%

Sectors

Manufacturing 73.0%
Health Care and Social Assistance 6.9%
Professional, Scientific, and Technical Services 2.1%
Wholesale Trade 0.6%
Information 0.5%
Other 17.0%

Countries

United States 95.4%
Ireland 4.6%
Other 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 69 investments below

69 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

Krystal Biotech Inc

KRYS - Manufacturing

Krystal Biotech Inc

KRYS - Manufacturing
Market Cap $10.78B
P/E Ratio 47.2
Dividends 0.0%
Total Investment $5.92M
Weight 4.24%

Loading details…

Glaukos Corporation

GKOS - Manufacturing

Glaukos Corporation

GKOS - Manufacturing
Market Cap $8.97B
P/E Ratio -46.6
Dividends 0.0%
Total Investment $5.76M
Weight 4.12%

Loading details…

PTC Therapeutics Inc

PTCT - Manufacturing

PTC Therapeutics Inc

PTCT - Manufacturing
Market Cap $7.04B
P/E Ratio -36.4
Dividends 0.0%
Total Investment $4.56M
Weight 3.26%

Loading details…

Protagonist Therapeutics Inc

PTGX - Manufacturing

Protagonist Therapeutics Inc

PTGX - Manufacturing
Market Cap $8.45B
P/E Ratio -72.9
Dividends 0.0%
Total Investment $4.5M
Weight 3.22%

Loading details…

Teleflex Incorporated

TFX - Manufacturing

Teleflex Incorporated

TFX - Manufacturing
Market Cap $6.01B
P/E Ratio -6.0
Dividends 1.0%
Total Investment $4.49M
Weight 3.21%

Loading details…

Transmedics Group Inc

TMDX - Manufacturing

Transmedics Group Inc

TMDX - Manufacturing
Market Cap $2.46B
P/E Ratio 14.2
Dividends 0.0%
Total Investment $4.13M
Weight 2.96%

Loading details…

Radnet Inc

RDNT - Manufacturing

Radnet Inc

RDNT - Manufacturing
Market Cap $5.16B
P/E Ratio -371.7
Dividends 0.0%
Total Investment $4.03M
Weight 2.89%

Loading details…

BrightSpring Health Services Inc

BTSG

BrightSpring Health Services Inc

BTSG
Market Cap $14.09B
P/E Ratio 47.0
Dividends 0.0%
Total Investment $3.92M
Weight 2.80%

Loading details…

Merit Medical Systems, Inc.

MMSI - Manufacturing

Merit Medical Systems, Inc.

MMSI - Manufacturing
Market Cap $4.38B
P/E Ratio 31.3
Dividends 0.0%
Total Investment $3.81M
Weight 2.73%

Loading details…

TG Therapeutics Inc

TGTX - Manufacturing

TG Therapeutics Inc

TGTX - Manufacturing
Market Cap $8.74B
P/E Ratio 18.0
Dividends 0.0%
Total Investment $3.41M
Weight 2.44%

Loading details…

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

LGND - Manufacturing

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

LGND - Manufacturing
Market Cap $6.34B
P/E Ratio 40.3
Dividends 0.0%
Total Investment $3.25M
Weight 2.32%

Loading details…

ICU Medical, Inc.

ICUI - Manufacturing

ICU Medical, Inc.

ICUI - Manufacturing
Market Cap $3.86B
P/E Ratio 82.6
Dividends 0.0%
Total Investment $3.09M
Weight 2.21%

Loading details…

Corcept Therapeutics Inc

CORT - Manufacturing

Corcept Therapeutics Inc

CORT - Manufacturing
Market Cap $9.86B
P/E Ratio 204.2
Dividends 0.0%
Total Investment $2.78M
Weight 1.99%

Loading details…

Prestige Consumer Healthcare Inc

PBH - Manufacturing

Prestige Consumer Healthcare Inc

PBH - Manufacturing
Market Cap $2.32B
P/E Ratio 12.4
Dividends 0.0%
Total Investment $2.77M
Weight 1.98%

Loading details…

Supernus Pharmaceuticals Inc

SUPN - Manufacturing

Supernus Pharmaceuticals Inc

SUPN - Manufacturing
Market Cap $2.81B
P/E Ratio -94.8
Dividends 0.0%
Total Investment $2.61M
Weight 1.87%

Loading details…

Acadia Pharmaceuticals Inc

ACAD - Manufacturing

Acadia Pharmaceuticals Inc

ACAD - Manufacturing
Market Cap $4.49B
P/E Ratio 11.8
Dividends 0.0%
Total Investment $2.56M
Weight 1.83%

Loading details…

Integer Holdings Corp

ITGR - Manufacturing

Integer Holdings Corp

ITGR - Manufacturing
Market Cap $3.18B
P/E Ratio 23.1
Dividends 0.0%
Total Investment $2.53M
Weight 1.81%

Loading details…

Waystar Holding Corp

WAY

Waystar Holding Corp

WAY
Market Cap $4.3B
P/E Ratio 32.0
Dividends 0.0%
Total Investment $2.45M
Weight 1.75%

Loading details…

Veracyte Inc

VCYT - Health Care and Social Assistance

Veracyte Inc

VCYT - Health Care and Social Assistance
Market Cap $4.55B
P/E Ratio 51.4
Dividends 0.0%
Total Investment $2.41M
Weight 1.72%

Loading details…

Concentra Group Holdings Parent Inc.

CON

Concentra Group Holdings Parent Inc.

CON
Market Cap $4.04B
P/E Ratio 22.7
Dividends 0.8%
Total Investment $2.38M
Weight 1.70%

Loading details…